OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CINYSE64

Cigna Group

Managed HealthcareVerified

Cigna Group (CI) is currently classified as Healthcare Services & Equipment within Managed Healthcare (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 153,266,000,000 USD, total equity 42,210,000,000, short-term debt 0, long-term debt 29,371,000,000. Net cash position is approximately -21,519,000,000 USD. Profitability profile: revenue 68,494,000,000, gross profit 0, operating income 2,358,000,000, net income 1,654,000,000. Return on equity ~3.9%. Return on assets ~1.1%. Operating-cash-flow to net-income ratio is 0.68. Risk profile from automated assessment: liquidity risk high, dilution risk medium. Flags: Current liabilities exceed current assets.; Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Management commentary signal: or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement..

30-day price · CI+35.36 (+13.4%)
Low$257.85High$303.33Close$299.93As of14 May, 00:00 UTC
Profile
CompanyCigna Group
ExchangeNYSE
TickerCI
CIK0001739940
SICHospital & Medical Service Plans
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryManaged Healthcare
AI analysis

Business. Cigna Group is classified under Healthcare / Managed Healthcare and appears profitable on the latest normalized snapshot.

Classification. Classification confidence is 0.92 based on verified market data; matched terms: Managed Healthcare, Healthcare Services & Equipment, Healthcare.

Cigna Group (CI) is currently classified as Healthcare Services & Equipment within Managed Healthcare (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 153,266,000,000 USD, total equity 42,210,000,000, short-term debt 0, long-term debt 29,371,000,000. Net cash position is approximately -21,519,000,000 USD. Profitability profile: revenue 68,494,000,000, gross profit 0, operating income 2,358,000,000, net income 1,654,000,000. Return on equity ~3.9%. Return on assets ~1.1%. Operating-cash-flow to net-income ratio is 0.68. Risk profile from automated assessment: liquidity risk high, dilution risk medium. Flags: Current liabilities exceed current assets.; Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Management commentary signal: or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement..
Key takeaways
  • Return on equity is about 3.9%.
  • Debt to equity is about 0.7x.
  • Management signal detected: or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.
  • Companyfacts coverage was partial; recent filing facts backfilled property_and_equipment, shares_outstanding_basic.
Financial snapshot
PeriodQ1 2026
CurrencyUSD
Revenue$68.49B
Gross profit
Operating income$2.36B
Net income$1.65B
R&D
SG&A
D&A$650.0M
SBC
Operating cash flow$1.13B
CapEx
Free cash flow
Total assets$153.27B
Total liabilities$110.82B
Total equity$42.21B
Cash & equivalents$7.04B
Long-term debt$29.37B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$274.90B$9.20B$5.96B
FY2024$247.12B$9.42B
FY2025$247.12B$9.42B$3.43B
FY2023$195.26B$8.54B
FY2024$195.26B$8.54B
PeriodGross %Op %Net %FCF %
FY2025
FY2024
FY2025
FY2023
FY2024
PeriodAssetsEquityCashDebt
FY2025$157.92B$41.71B$7.68B
FY2024$155.88B$41.03B$7.55B
FY2025$155.88B$41.03B$7.55B
FY2023$152.76B$46.22B$7.82B
FY2024$152.76B$46.22B$7.82B
PeriodOCFCapExFCFSBC
FY2025$9.60B$291.0M
FY2024$10.36B$308.0M
FY2025$10.36B$308.0M
FY2023$11.81B$286.0M
FY2024$11.81B$286.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q1 2026$68.49B$2.36B$1.65B
Q1 2026
Q3 2025$202.43B$6.86B
Q2 2025$132.68B$4.28B
PeriodGross %Op %Net %FCF %
Q1 2026
Q1 2026
Q3 2025
Q2 2025
PeriodAssetsEquityCashDebt
Q1 2026$153.27B$42.21B$7.04B
Q1 2026$157.92B$41.71B$7.68B
Q3 2025$157.92B$41.80B$6.03B
Q2 2025$151.65B$40.21B$4.33B
PeriodOCFCapExFCFSBC
Q1 2026$1.13B
Q1 2026
Q3 2025$3.45B
Q2 2025$34.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$30.41B
Net cash-$21.52B
Current ratio0.8
Debt/Equity0.7
ROA1.1%
ROE3.9%
Cash conversion68.0%
CapEx/Revenue
SBC/Revenue
Asset intensity0.0
Dilution ratio0.2%
Risk assessment
Dilution riskMedium
Liquidity riskHigh
  • Current liabilities exceed current assets.
  • Net cash is negative after subtracting total debt.
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricCIActivity
Op margin3.4%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin2.4%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin64.0% medp25 60.1% · p75 65.6%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue3.0% medp25 2.7% · p75 4.5%
Debt / equity70.0%69.3% medp25 63.4% · p75 74.5%above median
Observations
IR observations
Mean price target337.24 USD
Median price target337.00 USD
High price target378.00 USD
Low price target290.00 USD
Mean recommendation1.85 (1=strong buy, 5=strong sell)
Strong-buy count8.00
Buy count14.00
Hold count4.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate30.34 USD
Last actual EPS29.84 USD
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 04:16 UTCJob: 9a2375b4